Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: PD-L1, . Treffer: 21

2020

Brcic, I; Gallob, M; Schwantzer, G; Zrnc, T; Weiland, T; Thurnher, D; Wolf, A; Brcic, L Concordance of tumor infiltrating lymphocytes, PD-L1 and p16 expression in small biopsies, resection and lymph node metastases of oropharyngeal squamous cell carcinoma.
Oral Oncol. 2020; 106: 104719-104719.
Web of Science PubMed FullText FullText_MUG

 

Mir Seyed Nazari, P; Berghoff, AS; Preusser, M; Moik, F; Posch, F; Ricken, G; Riedl, J; Hell, L; Marosi, C; Hainfellner, JA; Pabinger, I; Ay, C Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma.
ESMO Open. 2020; 5(3): [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Riedl, JM; Barth, DA; Brueckl, WM; Zeitler, G; Foris, V; Mollnar, S; Stotz, M; Rossmann, CH; Terbuch, A; Balic, M; Niedrist, T; Bertsch, T; Stoeger, H; Pichler, M; Olschewski, H; Absenger, G; Ficker, JH; Gerger, A; Posch, F C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel). 2020; 12(8):
PubMed FullText FullText_MUG

 

Suppan, C; Balic, M Treatment options in early triple-negative breast cancer Update from the San Antonio Breast Cancer Symposium 2019
MEMO-MAG EUR MED ONC. 2020;
Web of Science FullText FullText_MUG

 

2019

Pichler, R; Compérat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Cancers (Basel). 2019; 11(3): 422 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Riethdorf, S; Hildebrandt, L; Heinzerling, L; Heitzer, E; Fischer, N; Bergmann, S; Mauermann, O; Waldispühl-Geigl, J; Coith, C; Schön, G; Peine, S; Schuler, G; Speicher, MR; Moll, I; Pantel, K Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma.
CLIN CHEM. 2019; 65(3): 462-472.
Web of Science PubMed FullText FullText_MUG

 

Schmoeckel, E; Hofmann, S; Fromberger, D; Rottmann, M; Luthardt, B; Burges, A; Jeschke, U; Kirchner, T; Lax, SF; Mayr, D Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.
Virchows Arch. 2019; 474(5):599-608
Web of Science PubMed FullText FullText_MUG

 

Smolle, E; Leithner, K; Olschewski, H Oncogene addiction and tumor mutational burden in non-small-cell lung cancer: Clinical significance and limitations.
Thorac Cancer. 2019; [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Smolle, MA; Prinz, F; Calin, GA; Pichler, M Current concepts of non-coding RNA regulation of immune checkpoints in cancer.
Mol Aspects Med. 2019; 70:117-126
Web of Science PubMed FullText FullText_MUG

 

van Seijen, M; Brcic, L; Gonzales, AN; Sansano, I; Bendek, M; Brcic, I; Lissenberg-Witte, B; Korkmaz, HI; Geiger, T; Kammler, R; Stahel, R; Thunnissen, E; ETOP Impact of delayed and prolonged fixation on the evaluation of immunohistochemical staining on lung carcinoma resection specimen.
Virchows Arch. 2019; 475(2):191-199 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Walsh, NM; Castonguay, MC; Carter, MD; Pasternak, S; Ly, TY; Doucette, S; Hanly, JG; Saggini, A; Cerroni, L Global PD-L1 Signals and Tumor-Infiltrating Lymphocytes: Markers of Immunogenicity in Different Subsets of Merkel Cell Carcinoma and Potential Therapeutic Implications
AM J DERMATOPATH. 2019; 41(11): 819-825.
Web of Science PubMed FullText FullText_MUG

 

2018

Carlino, MS; Long, GV; Schadendorf, D; Robert, C; Ribas, A; Richtig, E; Nyakas, M; Caglevic, C; Tarhini, A; Blank, C; Hoeller, C; Bar-Sela, G; Barrow, C; Wolter, P; Zhou, H; Emancipator, K; Jensen, EH; Ebbinghaus, S; Ibrahim, N; Daud, A Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial.
EUR J CANCER. 2018; 101(3): 236-243. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zaric, B; Brcic, L; Buder, A; Brandstetter, A; Buresch, JO; Traint, S; Kovacevic, T; Stojsic, V; Perin, B; Pirker, R; Filipits, M PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma.
Clin Lung Cancer. 2018; 19(6):e957-e963-e957-e963
Web of Science PubMed FullText FullText_MUG

 

Zhou, XA; Louissaint, A; Wenzel, A; Yang, J; Martinez-Escala, ME; Moy, AP; Morgan, EA; Paxton, CN; Hong, B; Andersen, EF; Guitart, J; Behdad, A; Cerroni, L; Weinstock, DM; Choi, J Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
J INVEST DERMATOL. 2018; 138(11): 2365-2376. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Smolle, MA; Calin, HN; Pichler, M; Calin, GA Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeutics.
FEBS J. 2017; 284(13):1952-1966 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Walsh, NM; Fleming, KE; Hanly, JG; Dakin Hache, K; Doucette, S; Ferrara, G; Cerroni, L A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
Hum Pathol. 2016; 52(6):190-196
Web of Science PubMed FullText FullText_MUG

 

2015

Mischinger, J; Comperat, E; Schwentner, C; Stenzl, A; Gakis, G Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?
Curr Urol Rep. 2015; 16(9):59-59
Web of Science PubMed FullText FullText_MUG

 

2014

Becker, JC; thor Straten, P; Andersen, MH Self-reactive T cells: suppressing the suppressors.
Cancer Immunol Immunother. 2014; 63(4):313-319
Web of Science PubMed FullText FullText_MUG

 

Rong, Z; Wang, M; Hu, Z; Stradner, M; Zhu, S; Kong, H; Yi, H; Goldrath, A; Yang, YG; Xu, Y; Fu, X An effective approach to prevent immune rejection of human ESC-derived allografts.
Cell Stem Cell. 2014; 14(1):121-130 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Kronsteiner, B; Wolbank, S; Peterbauer, A; Hackl, C; Redl, H; van Griensven, M; Gabriel, C Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells.
Stem Cells Dev. 2011; 20(12): 2115-2126.
Web of Science PubMed FullText FullText_MUG

 

2003

Petroff, MG; Chen, L; Phillips, TA; Azzola, D; Sedlmayr, P; Hunt, JS B7 family molecules are favorably positioned at the human maternal-fetal interface.
Biol Reprod. 2003; 68(5):1496-1504 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum